DPYD and dihydropyrimidine dehydrogenase deficiency: We have shown that inclusion of rare DPYD variants identified in patients with DPD deficiency and with supporting evidence of a functional impact on DPD activity does not compromise prediction of 5-FU related toxicity and provides small improvements in the ability to predict risk of haematological toxicities.